APO Research
Talk to an analyst

APO RESEARCH · REPORT

Behavioral Health Guidance

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Behavioral Health Guidance Market Outlook and Growth Opportunities 2026

4 June 2026214 pages

Choose your research edition.

Industry ResearchBehavioral Health Guidance Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Behavioral Health Guidance Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Behavioral Health Guidance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Behavioral Health Guidance Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Behavioral Health Guidance Market Analysis and Forecast 2026-2032225 pages · $4,950 USD

Market perspective

The global Behavioral Health Guidance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Behavioral Health Guidance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Behavioral Health Guidance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Behavioral Health Guidance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Behavioral Health Guidance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Behavioral Health Guidance market include Acadia Healthcare, Priory Group, BetterHelp, Headspace, Talkspace, Lyra Health, Spring Health, Ramsay Mental Health and Cygnet Health Care, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Behavioral Health Guidance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Behavioral Health Guidance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Behavioral Health Guidance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Behavioral Health Guidance market.

Behavioral Health Guidance Segment by Company

Acadia Healthcare

Priory Group

BetterHelp

Headspace

Talkspace

Lyra Health

Spring Health

Ramsay Mental Health

Cygnet Health Care

Rogers Behavioral Health

Kooth

Intellect

ThoughtFull World

Modern Health

Unmind

OpenUp

Mindler

Healios

Wysa

HelloBetter

My Mirror

Inkblot Therapy

Trost

MindCafe

Mabo

xinli001

haoxinqing

zhaoyang doctor

Behavioral Health Guidance Segment by Type

Cognitive Behavioral Therapy Interventions

Mindfulness Meditation Training

Biofeedback Regulation

Others

Behavioral Health Guidance Segment by Application

Healthcare Industry

Education Industry

Wellness and Health Services Industry

Others

Behavioral Health Guidance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Behavioral Health Guidance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Behavioral Health Guidance key companies, revenue, market share, and recent developments.

3. To split the Behavioral Health Guidance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Behavioral Health Guidance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Behavioral Health Guidance significant trends, drivers, influence factors in global and regions.

6. To analyze Behavioral Health Guidance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Behavioral Health Guidance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Behavioral Health Guidance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Behavioral Health Guidance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Behavioral Health Guidance industry.

Chapter 3: Detailed analysis of Behavioral Health Guidance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Behavioral Health Guidance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Behavioral Health Guidance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Behavioral Health Guidance Industry Trends Table 2. Behavioral Health Guidance Industry Drivers Table 3. Behavioral Health Guidance Industry Opportunities and Challenges Table 4. Behavioral Health Guidance Industry Restraints Table 5. Global Behavioral Health Guidance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Behavioral Health Guidance Revenue Share by Company (2021-2026) Table 7. Global Behavioral Health Guidance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Behavioral Health Guidance Key Company Manufacturing Base & Headquarters Table 9. Global Behavioral Health Guidance Company, Product Type & Application Table 10. Global Behavioral Health Guidance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Behavioral Health Guidance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cognitive Behavioral Therapy Interventions Table 15. Significant Companies of Mindfulness Meditation Training Table 16. Significant Companies of Biofeedback Regulation Table 17. Significant Companies of Others Table 18. Global Behavioral Health Guidance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Behavioral Health Guidance Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Behavioral Health Guidance Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Behavioral Health Guidance Sales Value Share by Type (2021-2026) Table 22. Global Behavioral Health Guidance Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Healthcare Industry Table 24. Significant Companies of Education Industry Table 25. Significant Companies of Wellness and Health Services Industry Table 26. Significant Companies of Others Table 27. Global Behavioral Health Guidance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Behavioral Health Guidance Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Behavioral Health Guidance Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Behavioral Health Guidance Sales Value Share by Application (2021-2026) Table 31. Global Behavioral Health Guidance Sales Value Share by Application (2027-2032) Table 32. Global Behavioral Health Guidance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Behavioral Health Guidance Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Behavioral Health Guidance Sales Value Share by Region (2021-2026) Table 35. Global Behavioral Health Guidance Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Behavioral Health Guidance Sales Value Share by Region (2027-2032) Table 37. Global Behavioral Health Guidance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Behavioral Health Guidance Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Behavioral Health Guidance Sales Value Market Share by Country (2021-2026) Table 40. Global Behavioral Health Guidance Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Behavioral Health Guidance Sales Value Market Share by Country (2027-2032) Table 42. Acadia Healthcare Company Information Table 43. Acadia Healthcare Business Overview Table 44. Acadia Healthcare Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Acadia Healthcare Behavioral Health Guidance Product Portfolio Table 46. Acadia Healthcare Recent Development Table 47. Priory Group Company Information Table 48. Priory Group Business Overview Table 49. Priory Group Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Priory Group Behavioral Health Guidance Product Portfolio Table 51. Priory Group Recent Development Table 52. BetterHelp Company Information Table 53. BetterHelp Business Overview Table 54. BetterHelp Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BetterHelp Behavioral Health Guidance Product Portfolio Table 56. BetterHelp Recent Development Table 57. Headspace Company Information Table 58. Headspace Business Overview Table 59. Headspace Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Headspace Behavioral Health Guidance Product Portfolio Table 61. Headspace Recent Development Table 62. Talkspace Company Information Table 63. Talkspace Business Overview Table 64. Talkspace Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Talkspace Behavioral Health Guidance Product Portfolio Table 66. Talkspace Recent Development Table 67. Lyra Health Company Information Table 68. Lyra Health Business Overview Table 69. Lyra Health Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lyra Health Behavioral Health Guidance Product Portfolio Table 71. Lyra Health Recent Development Table 72. Spring Health Company Information Table 73. Spring Health Business Overview Table 74. Spring Health Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Spring Health Behavioral Health Guidance Product Portfolio Table 76. Spring Health Recent Development Table 77. Ramsay Mental Health Company Information Table 78. Ramsay Mental Health Business Overview Table 79. Ramsay Mental Health Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ramsay Mental Health Behavioral Health Guidance Product Portfolio Table 81. Ramsay Mental Health Recent Development Table 82. Cygnet Health Care Company Information Table 83. Cygnet Health Care Business Overview Table 84. Cygnet Health Care Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Cygnet Health Care Behavioral Health Guidance Product Portfolio Table 86. Cygnet Health Care Recent Development Table 87. Rogers Behavioral Health Company Information Table 88. Rogers Behavioral Health Business Overview Table 89. Rogers Behavioral Health Behavioral Health Guidance Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Rogers Behavioral Health Behavioral Health Guidance Product Portfolio Table 91. Rogers Behavioral Health Recent Development Table 92. Kooth Company Information Table 93. Kooth Business Overview Table 94. Kooth Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Kooth Behavioral Health Guidance Product Portfolio Table 96. Kooth Recent Development Table 97. Intellect Company Information Table 98. Intellect Business Overview Table 99. Intellect Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Intellect Behavioral Health Guidance Product Portfolio Table 101. Intellect Recent Development Table 102. ThoughtFull World Company Information Table 103. ThoughtFull World Business Overview Table 104. ThoughtFull World Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. ThoughtFull World Behavioral Health Guidance Product Portfolio Table 106. ThoughtFull World Recent Development Table 107. Modern Health Company Information Table 108. Modern Health Business Overview Table 109. Modern Health Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Modern Health Behavioral Health Guidance Product Portfolio Table 111. Modern Health Recent Development Table 112. Unmind Company Information Table 113. Unmind Business Overview Table 114. Unmind Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Unmind Behavioral Health Guidance Product Portfolio Table 116. Unmind Recent Development Table 117. OpenUp Company Information Table 118. OpenUp Business Overview Table 119. OpenUp Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. OpenUp Behavioral Health Guidance Product Portfolio Table 121. OpenUp Recent Development Table 122. Mindler Company Information Table 123. Mindler Business Overview Table 124. Mindler Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Mindler Behavioral Health Guidance Product Portfolio Table 126. Mindler Recent Development Table 127. Healios Company Information Table 128. Healios Business Overview Table 129. Healios Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Healios Behavioral Health Guidance Product Portfolio Table 131. Healios Recent Development Table 132. Wysa Company Information Table 133. Wysa Business Overview Table 134. Wysa Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Wysa Behavioral Health Guidance Product Portfolio Table 136. Wysa Recent Development Table 137. HelloBetter Company Information Table 138. HelloBetter Business Overview Table 139. HelloBetter Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. HelloBetter Behavioral Health Guidance Product Portfolio Table 141. HelloBetter Recent Development Table 142. My Mirror Company Information Table 143. My Mirror Business Overview Table 144. My Mirror Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. My Mirror Behavioral Health Guidance Product Portfolio Table 146. My Mirror Recent Development Table 147. Inkblot Therapy Company Information Table 148. Inkblot Therapy Business Overview Table 149. Inkblot Therapy Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Inkblot Therapy Behavioral Health Guidance Product Portfolio Table 151. Inkblot Therapy Recent Development Table 152. Trost Company Information Table 153. Trost Business Overview Table 154. Trost Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Trost Behavioral Health Guidance Product Portfolio Table 156. Trost Recent Development Table 157. MindCafe Company Information Table 158. MindCafe Business Overview Table 159. MindCafe Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. MindCafe Behavioral Health Guidance Product Portfolio Table 161. MindCafe Recent Development Table 162. Mabo Company Information Table 163. Mabo Business Overview Table 164. Mabo Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Mabo Behavioral Health Guidance Product Portfolio Table 166. Mabo Recent Development Table 167. xinli001 Company Information Table 168. xinli001 Business Overview Table 169. xinli001 Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. xinli001 Behavioral Health Guidance Product Portfolio Table 171. xinli001 Recent Development Table 172. haoxinqing Company Information Table 173. haoxinqing Business Overview Table 174. haoxinqing Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. haoxinqing Behavioral Health Guidance Product Portfolio Table 176. haoxinqing Recent Development Table 177. zhaoyang doctor Company Information Table 178. zhaoyang doctor Business Overview Table 179. zhaoyang doctor Behavioral Health Guidance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. zhaoyang doctor Behavioral Health Guidance Product Portfolio Table 181. zhaoyang doctor Recent Development Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Behavioral Health Guidance Product Image Figure 2. Global Behavioral Health Guidance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Behavioral Health Guidance Market Size (2021-2032) & (US$ Million) Figure 4. Global Behavioral Health Guidance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cognitive Behavioral Therapy Interventions Image Figure 8. Mindfulness Meditation Training Image Figure 9. Biofeedback Regulation Image Figure 10. Others Image Figure 11. Global Behavioral Health Guidance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Behavioral Health Guidance Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Behavioral Health Guidance Sales Value Share by Type (2021-2032) Figure 14. Healthcare Industry Image Figure 15. Education Industry Image Figure 16. Wellness and Health Services Industry Image Figure 17. Others Image Figure 18. Global Behavioral Health Guidance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Behavioral Health Guidance Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Behavioral Health Guidance Sales Value Share by Application (2021-2032) Figure 21. Global Behavioral Health Guidance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Behavioral Health Guidance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Behavioral Health Guidance Sales Value (2021-2032) & (US$ Million) Figure 24. North America Behavioral Health Guidance Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Behavioral Health Guidance Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Behavioral Health Guidance Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Behavioral Health Guidance Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Behavioral Health Guidance Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Behavioral Health Guidance Sales Value (2021-2032) & (US$ Million) Figure 30. South America Behavioral Health Guidance Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Behavioral Health Guidance Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Behavioral Health Guidance Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Behavioral Health Guidance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Cognitive Behavioral Therapy Interventions
  • Mindfulness Meditation Training
  • Biofeedback Regulation
  • Others
Applications
  • Healthcare Industry
  • Education Industry
  • Wellness and Health Services Industry
  • Others
Companies covered
  • Acadia Healthcare
  • Priory Group
  • BetterHelp
  • Headspace
  • Talkspace
  • Lyra Health
  • Spring Health
  • Ramsay Mental Health
  • Cygnet Health Care
  • Rogers Behavioral Health
  • Kooth
  • Intellect
  • ThoughtFull World
  • Modern Health
  • Unmind
  • OpenUp
  • Mindler
  • Healios
  • Wysa
  • HelloBetter
  • My Mirror
  • Inkblot Therapy
  • Trost
  • MindCafe
  • Mabo
  • xinli001
  • haoxinqing
  • zhaoyang doctor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Behavioral Health Guidance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Behavioral Health Guidance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Behavioral Health Guidance Market Dynamics
  1. 2.1 Behavioral Health Guidance Industry Trends
  2. 2.2 Behavioral Health Guidance Industry Drivers
  3. 2.3 Behavioral Health Guidance Industry Opportunities and Challenges
  4. 2.4 Behavioral Health Guidance Industry Restraints
3 Behavioral Health Guidance Market by Company
  1. 3.1 Global Behavioral Health Guidance Company Revenue Ranking in 2025
  2. 3.2 Global Behavioral Health Guidance Revenue by Company (2021-2026)
  3. 3.3 Global Behavioral Health Guidance Company Ranking (2024-2026)
  4. 3.4 Global Behavioral Health Guidance Company Manufacturing Base and Headquarters
  5. 3.5 Global Behavioral Health Guidance Company Product Type and Application
  6. 3.6 Global Behavioral Health Guidance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Behavioral Health Guidance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Behavioral Health Guidance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Behavioral Health Guidance Market by Type
  1. 4.1 Behavioral Health Guidance Type Introduction
  2. 4.1.1 Cognitive Behavioral Therapy Interventions
  3. 4.1.2 Mindfulness Meditation Training
  4. 4.1.3 Biofeedback Regulation
  5. 4.1.4 Others
  6. 4.2 Global Behavioral Health Guidance Sales Value by Type
  7. 4.2.1 Global Behavioral Health Guidance Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Behavioral Health Guidance Sales Value by Type (2021-2032)
  9. 4.2.3 Global Behavioral Health Guidance Sales Value Share by Type (2021-2032)
5 Behavioral Health Guidance Market by Application
  1. 5.1 Behavioral Health Guidance Application Introduction
  2. 5.1.1 Healthcare Industry
  3. 5.1.2 Education Industry
  4. 5.1.3 Wellness and Health Services Industry
  5. 5.1.4 Others
  6. 5.2 Global Behavioral Health Guidance Sales Value by Application
  7. 5.2.1 Global Behavioral Health Guidance Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Behavioral Health Guidance Sales Value by Application (2021-2032)
  9. 5.2.3 Global Behavioral Health Guidance Sales Value Share by Application (2021-2032)
6 Behavioral Health Guidance Regional Value Analysis
  1. 6.1 Global Behavioral Health Guidance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Behavioral Health Guidance Sales Value by Region (2021-2032)
  3. 6.2.1 Global Behavioral Health Guidance Sales Value by Region: 2021-2026
  4. 6.2.2 Global Behavioral Health Guidance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Behavioral Health Guidance Sales Value (2021-2032)
  7. 6.3.2 North America Behavioral Health Guidance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Behavioral Health Guidance Sales Value (2021-2032)
  10. 6.4.2 Europe Behavioral Health Guidance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Behavioral Health Guidance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Behavioral Health Guidance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Behavioral Health Guidance Sales Value (2021-2032)
  16. 6.6.2 South America Behavioral Health Guidance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Behavioral Health Guidance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Behavioral Health Guidance Sales Value Share by Country, 2025 VS 2032
7 Behavioral Health Guidance Country-level Value Analysis
  1. 7.1 Global Behavioral Health Guidance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Behavioral Health Guidance Sales Value by Country (2021-2032)
  3. 7.2.1 Global Behavioral Health Guidance Sales Value by Country (2021-2026)
  4. 7.2.2 Global Behavioral Health Guidance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Behavioral Health Guidance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Behavioral Health Guidance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Behavioral Health Guidance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acadia Healthcare
  2. 8.1.1 Acadia Healthcare Company Information
  3. 8.1.2 Acadia Healthcare Business Overview
  4. 8.1.3 Acadia Healthcare Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acadia Healthcare Behavioral Health Guidance Product Portfolio
  6. 8.1.5 Acadia Healthcare Recent Developments
  7. 8.2 Priory Group
  8. 8.2.1 Priory Group Company Information
  9. 8.2.2 Priory Group Business Overview
  10. 8.2.3 Priory Group Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Priory Group Behavioral Health Guidance Product Portfolio
  12. 8.2.5 Priory Group Recent Developments
  13. 8.3 BetterHelp
  14. 8.3.1 BetterHelp Company Information
  15. 8.3.2 BetterHelp Business Overview
  16. 8.3.3 BetterHelp Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BetterHelp Behavioral Health Guidance Product Portfolio
  18. 8.3.5 BetterHelp Recent Developments
  19. 8.4 Headspace
  20. 8.4.1 Headspace Company Information
  21. 8.4.2 Headspace Business Overview
  22. 8.4.3 Headspace Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Headspace Behavioral Health Guidance Product Portfolio
  24. 8.4.5 Headspace Recent Developments
  25. 8.5 Talkspace
  26. 8.5.1 Talkspace Company Information
  27. 8.5.2 Talkspace Business Overview
  28. 8.5.3 Talkspace Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Talkspace Behavioral Health Guidance Product Portfolio
  30. 8.5.5 Talkspace Recent Developments
  31. 8.6 Lyra Health
  32. 8.6.1 Lyra Health Company Information
  33. 8.6.2 Lyra Health Business Overview
  34. 8.6.3 Lyra Health Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lyra Health Behavioral Health Guidance Product Portfolio
  36. 8.6.5 Lyra Health Recent Developments
  37. 8.7 Spring Health
  38. 8.7.1 Spring Health Company Information
  39. 8.7.2 Spring Health Business Overview
  40. 8.7.3 Spring Health Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Spring Health Behavioral Health Guidance Product Portfolio
  42. 8.7.5 Spring Health Recent Developments
  43. 8.8 Ramsay Mental Health
  44. 8.8.1 Ramsay Mental Health Company Information
  45. 8.8.2 Ramsay Mental Health Business Overview
  46. 8.8.3 Ramsay Mental Health Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ramsay Mental Health Behavioral Health Guidance Product Portfolio
  48. 8.8.5 Ramsay Mental Health Recent Developments
  49. 8.9 Cygnet Health Care
  50. 8.9.1 Cygnet Health Care Company Information
  51. 8.9.2 Cygnet Health Care Business Overview
  52. 8.9.3 Cygnet Health Care Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cygnet Health Care Behavioral Health Guidance Product Portfolio
  54. 8.9.5 Cygnet Health Care Recent Developments
  55. 8.10 Rogers Behavioral Health
  56. 8.10.1 Rogers Behavioral Health Company Information
  57. 8.10.2 Rogers Behavioral Health Business Overview
  58. 8.10.3 Rogers Behavioral Health Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rogers Behavioral Health Behavioral Health Guidance Product Portfolio
  60. 8.10.5 Rogers Behavioral Health Recent Developments
  61. 8.11 Kooth
  62. 8.11.1 Kooth Company Information
  63. 8.11.2 Kooth Business Overview
  64. 8.11.3 Kooth Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kooth Behavioral Health Guidance Product Portfolio
  66. 8.11.5 Kooth Recent Developments
  67. 8.12 Intellect
  68. 8.12.1 Intellect Company Information
  69. 8.12.2 Intellect Business Overview
  70. 8.12.3 Intellect Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Intellect Behavioral Health Guidance Product Portfolio
  72. 8.12.5 Intellect Recent Developments
  73. 8.13 ThoughtFull World
  74. 8.13.1 ThoughtFull World Company Information
  75. 8.13.2 ThoughtFull World Business Overview
  76. 8.13.3 ThoughtFull World Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ThoughtFull World Behavioral Health Guidance Product Portfolio
  78. 8.13.5 ThoughtFull World Recent Developments
  79. 8.14 Modern Health
  80. 8.14.1 Modern Health Company Information
  81. 8.14.2 Modern Health Business Overview
  82. 8.14.3 Modern Health Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Modern Health Behavioral Health Guidance Product Portfolio
  84. 8.14.5 Modern Health Recent Developments
  85. 8.15 Unmind
  86. 8.15.1 Unmind Company Information
  87. 8.15.2 Unmind Business Overview
  88. 8.15.3 Unmind Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Unmind Behavioral Health Guidance Product Portfolio
  90. 8.15.5 Unmind Recent Developments
  91. 8.16 OpenUp
  92. 8.16.1 OpenUp Company Information
  93. 8.16.2 OpenUp Business Overview
  94. 8.16.3 OpenUp Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  95. 8.16.4 OpenUp Behavioral Health Guidance Product Portfolio
  96. 8.16.5 OpenUp Recent Developments
  97. 8.17 Mindler
  98. 8.17.1 Mindler Company Information
  99. 8.17.2 Mindler Business Overview
  100. 8.17.3 Mindler Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Mindler Behavioral Health Guidance Product Portfolio
  102. 8.17.5 Mindler Recent Developments
  103. 8.18 Healios
  104. 8.18.1 Healios Company Information
  105. 8.18.2 Healios Business Overview
  106. 8.18.3 Healios Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Healios Behavioral Health Guidance Product Portfolio
  108. 8.18.5 Healios Recent Developments
  109. 8.19 Wysa
  110. 8.19.1 Wysa Company Information
  111. 8.19.2 Wysa Business Overview
  112. 8.19.3 Wysa Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Wysa Behavioral Health Guidance Product Portfolio
  114. 8.19.5 Wysa Recent Developments
  115. 8.20 HelloBetter
  116. 8.20.1 HelloBetter Company Information
  117. 8.20.2 HelloBetter Business Overview
  118. 8.20.3 HelloBetter Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  119. 8.20.4 HelloBetter Behavioral Health Guidance Product Portfolio
  120. 8.20.5 HelloBetter Recent Developments
  121. 8.21 My Mirror
  122. 8.21.1 My Mirror Company Information
  123. 8.21.2 My Mirror Business Overview
  124. 8.21.3 My Mirror Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  125. 8.21.4 My Mirror Behavioral Health Guidance Product Portfolio
  126. 8.21.5 My Mirror Recent Developments
  127. 8.22 Inkblot Therapy
  128. 8.22.1 Inkblot Therapy Company Information
  129. 8.22.2 Inkblot Therapy Business Overview
  130. 8.22.3 Inkblot Therapy Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Inkblot Therapy Behavioral Health Guidance Product Portfolio
  132. 8.22.5 Inkblot Therapy Recent Developments
  133. 8.23 Trost
  134. 8.23.1 Trost Company Information
  135. 8.23.2 Trost Business Overview
  136. 8.23.3 Trost Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Trost Behavioral Health Guidance Product Portfolio
  138. 8.23.5 Trost Recent Developments
  139. 8.24 MindCafe
  140. 8.24.1 MindCafe Company Information
  141. 8.24.2 MindCafe Business Overview
  142. 8.24.3 MindCafe Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  143. 8.24.4 MindCafe Behavioral Health Guidance Product Portfolio
  144. 8.24.5 MindCafe Recent Developments
  145. 8.25 Mabo
  146. 8.25.1 Mabo Company Information
  147. 8.25.2 Mabo Business Overview
  148. 8.25.3 Mabo Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Mabo Behavioral Health Guidance Product Portfolio
  150. 8.25.5 Mabo Recent Developments
  151. 8.26 xinli001
  152. 8.26.1 xinli001 Company Information
  153. 8.26.2 xinli001 Business Overview
  154. 8.26.3 xinli001 Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  155. 8.26.4 xinli001 Behavioral Health Guidance Product Portfolio
  156. 8.26.5 xinli001 Recent Developments
  157. 8.27 haoxinqing
  158. 8.27.1 haoxinqing Company Information
  159. 8.27.2 haoxinqing Business Overview
  160. 8.27.3 haoxinqing Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  161. 8.27.4 haoxinqing Behavioral Health Guidance Product Portfolio
  162. 8.27.5 haoxinqing Recent Developments
  163. 8.28 zhaoyang doctor
  164. 8.28.1 zhaoyang doctor Company Information
  165. 8.28.2 zhaoyang doctor Business Overview
  166. 8.28.3 zhaoyang doctor Behavioral Health Guidance Revenue and Gross Margin (2021-2026)
  167. 8.28.4 zhaoyang doctor Behavioral Health Guidance Product Portfolio
  168. 8.28.5 zhaoyang doctor Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst